LEP and obesity disorder: Treatment with 17β-estradiol, leptin, IL-6, and TNF-α (ELIT) for obesity-related inflammation also decrease mitochondrial function and increase oxidative stress, aggressiveness, and motility in cell lines with low estrogen receptor beta (ERβ) expression101.